Company intelligence / Profile preview
Yipurun
Shanghai, Shanghai, Chinaen.puyibio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Yipurun is a China-based biotechnology company focused on the discovery and development of innovative small molecule therapeutics. The company leverages advanced structure-based drug design (SBDD) and computational chemistry platforms to target challenging biological pathways in oncology and metabolic disorders. Yipurun aims to address significant unmet medical needs by developing high-potency, selective drug candidates with optimized pharmacological profiles. Currently, the company's portfolio is primarily in the discovery and pre-clinical stages, supported by a team of experts in medicinal chemistry and structural biology.
- Therapeutic areas
- OncologyMetabolic Disorders
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Yipurun.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yipurun.